Breaking News, Collaborations & Alliances

Ori Biotech and Vineti Enter Non-Exclusive Partnership

Will produce a fully pre-integrated solution to modernize, fast-track, and streamline the manufacture and delivery of cell and gene therapies.

Author Image

By: Charlie Sternberg

Associate Editor

Ori Biotech, an innovator in cell and gene therapy manufacturing, and Vineti, a provider of digital enterprise platforms for cell and gene therapy supply chains, are partnering to produce a fully pre-integrated solution to modernize, fast-track, and streamline the manufacture and delivery of cell and gene therapies (CGTs).   Advanced therapies, such as cell therapies, gene therapies, and personalized cancer vaccines, require infrastructure as advanced as their science. However, systems to mana...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters